We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

75 hedge funds and large institutions have $6.3M invested in Ampio Pharmaceuticals Inc. in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

756% more call options, than puts

Call options by funds: $137K | Put options by funds: $16K

45% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 11

7% less funds holding

Funds holding: 81 → 75 (-6)

21% less capital invested

Capital invested by funds: $7.96M → $6.3M (-$1.66M)

40% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 15

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
75
Holders Change
-6
Holders Change %
-7.41%
% of All Funds
1.64%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
16
Reduced
11
Closed
15
Calls
$137K
Puts
$16K
Net Calls
+$121K
Net Calls Change
-$84K

Top Buyers

Rank Fund Capital Flow
1
PCMC
Private Capital Management (Colorado)
Colorado
+$290K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$290K
3
WWM
Western Wealth Management
Colorado
+$233K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$176K
5
Renaissance Technologies
Renaissance Technologies
New York
+$77.8K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$2.04M
2
Millennium Management
Millennium Management
New York
-$776K
3
Northern Trust
Northern Trust
Illinois
-$392K
4
Bank of America
Bank of America
North Carolina
-$234K
5
Goldman Sachs
Goldman Sachs
New York
-$191K
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
51
PNC Financial Services Group
Pennsylvania
$7K – – –
SS
52
Sunbelt Securities
Texas
$7K +$6.26K +47 New
BNP Paribas Financial Markets
53
BNP Paribas Financial Markets
France
$6.13K – – –
BCM
54
Brookstone Capital Management
Illinois
$6K – – –
PAG
55
Private Advisor Group
New Jersey
$6K +$5.6K +42 New
CAL
56
Capital Analysts LLC
Pennsylvania
$5K – – –
OC
57
Oppenheimer & Co
New York
$5K – – –
WA
58
WealthTrust Axiom
Pennsylvania
$5K – – –
Northwestern Mutual Wealth Management
59
Northwestern Mutual Wealth Management
Wisconsin
$4K – – –
Bank of America
60
Bank of America
North Carolina
$3K -$234K -1,759 -99%
LTFS
61
Ladenburg Thalmann Financial Services
Florida
$3K – – –
SCA
62
Stonebridge Capital Advisors
Minnesota
$3K – – –
CCM
63
Covington Capital Management
California
$2K – – –
RFM
64
Royal Fund Management
Florida
$2K – – –
TRCT
65
Tower Research Capital (TRC)
New York
$2K +$1.6K +12 New
APA
66
American Portfolios Advisors
New York
$1.5K – – –
AF
67
Allworth Financial
California
$1K – – –
CAGAS
68
Capital Advisory Group Advisory Services
Minnesota
$1K – – –
CFG
69
Citizens Financial Group
Rhode Island
$1K – – –
CTB
70
Country Trust Bank
Illinois
$1K – – –
MA
71
MUFG Americas
New York
$1K – – –
Royal Bank of Canada
72
Royal Bank of Canada
Ontario, Canada
$1K – – –
GEA
73
Glen Eagle Advisors
New Jersey
$501 – – –
SM
74
Sabby Management
Florida
– -$2.04M -17,551 Closed
Goldman Sachs
75
Goldman Sachs
New York
– -$191K -1,648 Closed
1 2
3
4

AMPE Hedge Fund Activity: Q3 2019 in Review

75 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2019, worth a combined $6.3M — down 21% from $7.96M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of AMPE and 9 opened new positions — a net loss of 6 holders — while 11 trimmed existing stakes and 16 added.

The largest buyer was Private Capital Management (Colorado), opening a new position worth an estimated $290K. The largest seller was Sabby Management, exiting entirely with an estimated $2.04M sold.

  • 75 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2019, down from 81 in Q2 2019.
  • Funds reported $6.3M of Ampio Pharmaceuticals Inc. stock for Q3 2019, down 21% quarter-over-quarter.
  • 9 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2019 and 15 closed out, a net change of -6 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2019 was Private Capital Management (Colorado), an estimated $290K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2019 was Sabby Management, an estimated $2.04M sold.

Based on aggregated 13F filings for Q3 2019.